Abhishek Singhal, associate director at Macquarie Capital Securities, says it is too early to come to a conclusion that all the FDA issues are behind Lupin. But he maintains that July 2015 inspection is all-clear is definitely a better situation for Lupin to be in rather than the entire 18 observations outstanding.
![Gadgets 360 With Technical Guruji: Ask TG [May 18, 2024]](https://c.ndtvimg.com/2024-05/cjtutn3k_ask-tg_640x480_18_May_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [May 18, 2024]")
![Gadgets 360 With Technical Guruji: News of the Week [May 18, 2024]](https://c.ndtvimg.com/2024-05/p2scd7ik_news-of-the-week_640x480_18_May_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: News of the Week [May 18, 2024]")
![Gadgets 360 With Technical Guruji: Did You Know? [May 18, 2024]](https://c.ndtvimg.com/2024-05/8oaifv4o_did-you-know_640x480_18_May_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Did You Know? [May 18, 2024]")
